Published in Nanoscale Res Lett on April 09, 2013
Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment. Nanoscale Res Lett (2013) 0.94
Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. Int J Nanomedicine (2015) 0.87
Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles. Biomed Res Int (2014) 0.77
The synergistic effects of low dose fluorouracil and TRAIL on TRAIL-resistant human gastric adenocarcinoma AGS cells. Biomed Res Int (2013) 0.77
Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell Int (2013) 0.75
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells. Front Pharmacol (2016) 0.75
Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy. Int J Nanomedicine (2015) 0.75
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer. Int J Nanomedicine (2017) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Apoptosis by death factor. Cell (1997) 14.42
Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov (2007) 11.46
Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 10.59
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Current status of polymeric gene delivery systems. Adv Drug Deliv Rev (2006) 3.04
Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small (2008) 2.74
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res (2005) 2.62
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine (2008) 2.48
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03
The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials (2005) 2.01
Tumor angiogenesis and tissue factor. Nat Med (1996) 1.58
PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun (Camb) (2006) 1.50
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer (2008) 1.45
Angiogenesis inhibition: a review. Pharmacol Ther (1994) 1.40
Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg (2007) 1.39
Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther (2007) 1.34
Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett (2007) 1.30
The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF(165). Biomaterials (2009) 1.29
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm (2007) 1.28
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine (2007) 1.21
High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine. J Control Release (2008) 1.19
Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redox-silent. Mol Pharmacol (2007) 1.11
Progress and prospects: gene therapy clinical trials (part 1). Gene Ther (2007) 1.09
Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Biomaterials (2009) 1.06
Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials (2009) 1.06
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol. BMC Cancer (2008) 1.03
Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes. J Control Release (2008) 1.02
Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release (2005) 1.01
pEPito: a significantly improved non-viral episomal expression vector for mammalian cells. BMC Biotechnol (2010) 0.97
Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin. Curr Oncol Rep (2001) 0.96
Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems. Vaccine (2008) 0.95
Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med (2006) 0.94
Process in the mechanisms of endostatin combined with radiotherapy. Cancer Lett (2009) 0.92
Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Integr Biol (Camb) (2011) 0.91
Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice. J Control Release (2011) 0.91
Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy. J Gene Med (2008) 0.91
The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials (2010) 0.87
Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine (Lond) (2012) 0.87
Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anticancer Drugs (2005) 0.86
Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model. Eur J Gynaecol Oncol (2011) 0.86
A novel preparation method for PLGA microspheres using non-halogenated solvents. J Control Release (2008) 0.85
Polymer-based non-viral gene delivery as a concept for the treatment of cancer. Pharmacol Rep (2010) 0.84
International progress in cancer gene therapy. Cancer Gene Ther (2008) 0.84
Angiogenesis in the pathobiology and treatment of vascular and malignant diseases. Ann Thorac Surg (1997) 0.84
Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection. Biomaterials (2010) 0.81
Surface functionalisation of PLGA nanoparticles for gene silencing. Biomaterials (2010) 0.81
Method for reverse transfection using gold colloid as a nano-scaffold. J Biosci Bioeng (2007) 0.80
Cytotoxicity and in vivo tissue compatibility of poly(amidoamine) with pendant aminobutyl group as a gene delivery vector. Biomaterials (2010) 0.80
Transfection activity of layer-by-layer plasmid DNA/poly(ethylenimine) films deposited on PLGA microparticles. Int J Pharm (2008) 0.79
MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 4.29
LRP4 serves as a coreceptor of agrin. Neuron (2008) 2.98
The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron (2007) 2.96
Neuregulin-1 enhances depolarization-induced GABA release. Neuron (2007) 2.89
Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure. Development (2002) 2.71
To build a synapse: signaling pathways in neuromuscular junction assembly. Development (2010) 2.65
Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci U S A (2007) 2.65
Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis (2012) 2.53
Retrograde regulation of motoneuron differentiation by muscle beta-catenin. Nat Neurosci (2008) 2.07
The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials (2005) 2.01
Focal adhesion kinase in netrin-1 signaling. Nat Neurosci (2004) 1.99
Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A (2009) 1.98
Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev Cell (2010) 1.97
Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1. Neuron (2002) 1.96
Conformation of the backbone in unfolded proteins. Chem Rev (2006) 1.93
Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J Biol Chem (2001) 1.87
Phosphatidylinositol transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth. Nat Cell Biol (2005) 1.74
Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron (2013) 1.73
Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci (2011) 1.72
Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem (2003) 1.68
Autotrophic growth of nitrifying community in an agricultural soil. ISME J (2011) 1.67
Polyproline II propensities from GGXGG peptides reveal an anticorrelation with beta-sheet scales. Proc Natl Acad Sci U S A (2005) 1.64
Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood (2010) 1.63
The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity (2003) 1.61
Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci (2004) 1.61
ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci U S A (2010) 1.59
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci U S A (2013) 1.57
Saliva microbiomes distinguish caries-active from healthy human populations. ISME J (2011) 1.55
Myosin X regulates netrin receptors and functions in axonal path-finding. Nat Cell Biol (2007) 1.55
The role of poly(ethylene glycol) in the formation of silver nanoparticles. J Colloid Interface Sci (2005) 1.53
Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet (2010) 1.52
Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res (2013) 1.52
Assessment of four DNA fragments (COI, 16S rDNA, ITS2, 12S rDNA) for species identification of the Ixodida (Acari: Ixodida). Parasit Vectors (2014) 1.51
VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J Cell Biol (2011) 1.50
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol (2011) 1.47
ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem (2008) 1.46
Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci (2011) 1.46
Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J Neurosci (2003) 1.45
Genome analyses of Icelandic strains of Sulfolobus islandicus, model organisms for genetic and virus-host interaction studies. J Bacteriol (2011) 1.45
The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J Neurosci (2009) 1.44
Environmental adaptation: genomic analysis of the piezotolerant and psychrotolerant deep-sea iron reducing bacterium Shewanella piezotolerans WP3. PLoS One (2008) 1.38
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res (2010) 1.36
Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons. Nat Neurosci (2011) 1.36
BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J Cell Biol (2004) 1.35
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine (2009) 1.32
Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma. Neuro Oncol (2012) 1.30
Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30
The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29
Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex. J Biol Chem (2005) 1.28
Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem (2004) 1.24
Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J Cell Biol (2003) 1.24
Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci (2010) 1.23
Erbin suppresses the MAP kinase pathway. J Biol Chem (2002) 1.23
HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Miner Res (2008) 1.23
ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport (2008) 1.22
Beta-catenin regulates acetylcholine receptor clustering in muscle cells through interaction with rapsyn. J Neurosci (2007) 1.22
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials (2009) 1.21
Regulation of osteoclast function and bone mass by RAGE. J Exp Med (2006) 1.21
A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater (2009) 1.21
Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol (2009) 1.19
Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction. Neuron (2007) 1.19
Metagenomic insights into the fibrolytic microbiome in yak rumen. PLoS One (2012) 1.17
Erbin enhances voltage-dependent facilitation of Ca(v)1.3 Ca2+ channels through relief of an autoinhibitory domain in the Ca(v)1.3 alpha1 subunit. J Neurosci (2007) 1.17
Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J (2009) 1.16
Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors. Mol Cell Neurosci (2005) 1.15
Structural basis of agrin-LRP4-MuSK signaling. Genes Dev (2012) 1.15
HSP90 beta regulates rapsyn turnover and subsequent AChR cluster formation and maintenance. Neuron (2008) 1.15
Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS One (2011) 1.14
Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation. Neuron (2012) 1.14
Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials (2013) 1.12
Implication of geranylgeranyltransferase I in synapse formation. Neuron (2003) 1.11
Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome. Am J Hum Genet (2010) 1.10
Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering. J Neurosci (2006) 1.09
Paclitaxel drug delivery systems. Expert Opin Drug Deliv (2013) 1.09
Cardioprotective effect of salvianolic acid B on large myocardial infarction mediated by reversing upregulation of leptin, endothelin pathways, and abnormal expression of SERCA2a, phospholamban in rats. J Ethnopharmacol (2008) 1.08
Beta-catenin interacts with MyoD and regulates its transcription activity. Mol Cell Biol (2008) 1.06
Neuromuscular junction as Achilles' heel: yet another autoantibody? Neurology (2015) 1.05
Preliminary characterization of the oral microbiota of Chinese adults with and without gingivitis. BMC Oral Health (2011) 1.05
The polyproline II conformation in short alanine peptides is noncooperative. Proc Natl Acad Sci U S A (2004) 1.05
Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment. Nanoscale Res Lett (2010) 1.04
Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants. Acta Crystallogr D Biol Crystallogr (2011) 1.04
Genetic control of host resistance to porcine reproductive and respiratory syndrome virus (PRRSV) infection. Virus Res (2010) 1.03
Sequencing and comparative analysis of the straw mushroom (Volvariella volvacea) genome. PLoS One (2013) 1.03
Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J Clin Invest (2013) 1.03
Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci (2012) 1.02
Erbin controls dendritic morphogenesis by regulating localization of delta-catenin. J Neurosci (2008) 1.02
Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner. J Biol Chem (2011) 1.01
Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer (2011) 1.01
Neighbor effect on PPII conformation in alanine peptides. J Am Chem Soc (2005) 1.01
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol (2010) 1.00
Erbin is required for myelination in regenerated axons after injury. J Neurosci (2012) 0.99
Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons. Biochem Biophys Res Commun (2007) 0.99
The higher barrier of darunavir and tipranavir resistance for HIV-1 protease. Biochem Biophys Res Commun (2011) 0.99
Erbin regulates NRG1 signaling and myelination. Proc Natl Acad Sci U S A (2009) 0.98
Wnt proteins regulate acetylcholine receptor clustering in muscle cells. Mol Brain (2012) 0.98
Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain. Mol Cell Biol (2007) 0.98
Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf. FASEB J (2003) 0.97
Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol (2007) 0.97